Clinical Trial Update: 5-ALA in Recurrent Glioma [NA]

View source ↗

Summary

An update on a clinical trial evaluating 5-ALA (5-aminolevulinic acid) in recurrent glioma; the current phase and status are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 5-ALA (5-aminolevulinic acid)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Glioma | NA | Status: UNKNOWN